Literature DB >> 33323274

Hospital and surgeon variation in 30-day complication rates after ventral hernia repair.

Ryan Howard1, Emily Johnson2, Nicholas L Berlin3, Zhaohui Fan4, Michael Englesbe5, Justin B Dimick6, Dana A Telem7.   

Abstract

BACKGROUND: Ventral hernia repair is an extremely common operation, however the variability in patient outcomes between individual hospitals and surgeons is unclear. We analyzed variability in 30-day complication rates and identified specific complications that contributed to this variability.
METHODS: Retrospective, cross-sectional analysis of 30-day complication rates following ventral hernia repair across 73 hospital and 978 surgeons between January 1, 2014 and December 31, 2018.
RESULTS: Data were collected on 19,007 patients who underwent VIHR at 73 hospitals across 978 surgeons. Adjusted complication rate among hospitals was 6.2% (range 4.3%-12.8%) and among surgeons was 6.2% (range 3.5%-26.8%). Variation between lowest and highest quartile surgeons was greatest for acute kidney injury (0.12% vs. 1.71%, P < 0.001), superficial surgical site infection (0.33% vs. 3.62%, P < 0.001), sepsis (0.27% vs. 2.47%, P < 0.001), and catheter-associated urinary tract infection (0.02% vs. 0.30%, P < 0.001).
CONCLUSION: After adjusting for a number of patient-specific clinical variables, there is significant variation in 30-day complication rates after ventral hernia repair. This represents a significant opportunity to improve patient outcomes.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hernia; Hernia repair; Outcomes; Surgery; Variation

Year:  2020        PMID: 33323274     DOI: 10.1016/j.amjsurg.2020.12.021

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  1 in total

1.  Variation of ventral and incisional hernia repairs in kidney transplant recipients.

Authors:  Quintin P Solano; Jyothi R Thumma; Cody Mullens; Ryan Howard; Anne Ehlers; Lia Delaney; Brian Fry; Mary Shen; Michael Englesbe; Justin Dimick; Dana Telem
Journal:  Surg Endosc       Date:  2022-08-12       Impact factor: 3.453

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.